Dr. Jeffrey Tomoya Fujimoto, MD

Dr. Fujimoto practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Fujimoto's NPI, 1033614920, was assigned on March 24, 2018. Dr. Fujimoto graduated from David Geffen School of Medicine at UCLA in 2018. Dr. Fujimoto's California license number on file is A164274.

Dr. Fujimoto's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Fujimoto's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Fujimoto is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Fujimoto to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fujimoto practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Fujimoto's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Fujimoto is board certified in sports medicine by the American Board of Emergency Medicine. Dr. Fujimoto has a license on file in California.

Dmand AI lists acid reflux, acute kidney failure, acute mini-stroke (TIA), adjustment disease, aneurysm, arthritis, asthma and cerebrovascular disease among the conditions Dr. Fujimoto treats.

CMS data shows 100 Medicare services from Dr. Fujimoto across 4 procedure codes in 2024, for 52 Medicare patients. Medicare paid $10,903 for them. Every service was in an office.

CMS counts 52 Medicare patients who saw Dr. Fujimoto in 2024. The largest group is 65 to 74, with 23 patients. 71% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fujimoto's median patient age at 59, with 37% women.

In 2024, Dr. Fujimoto wrote 140 Medicare Part D claims for 67 patients. 84% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $105 in total drug cost. In 2023, CMS named 575 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Fujimoto for performance year 2024, reported as part of a group. Dr. Fujimoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fujimoto as offering telehealth.

Dmand AI links 3 papers to Dr. Fujimoto, published from 2013 to 2014. Dr. Fujimoto's most frequent co-authors are Leah S. Karliner, MD, Ajith Malige and David M. Rempel, MD.

Dmand AI links Dr. Fujimoto to 3 clinical trials. Conditions studied include COVID-19 and Pneumonia, Viral. University of California, Los Angeles sponsors the most, 3.

CMS Open Payments shows 3 general payments to Dr. Fujimoto from 3 drug and device companies from 2023 to 2024. Grants make up the largest share, 97% of the total. Arthrex, Inc. paid the most, $10,000.

Dr. Fujimoto graduated from David Geffen School of Medicine at UCLA in 2018.

Dr. Fujimoto is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.